Advaxis (ADXS) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Ayala Pharmaceuticals, Inc. has agreed to sell most of its assets to Immunome, Inc., and as part of the deal, the company has clarified the terms of the $800,000 transaction bonus for their Chief Medical Officer, Dr. Andres Gutierrez. The bonus will waive certain payments or benefits if Dr. Gutierrez’s employment ends after the sale. However, if his employment ceases before the sale’s completion, the original terms of his 2018 employment agreement will remain in effect.
For further insights into ADXS stock, check out TipRanks’ Stock Analysis page.